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common cause of liver disease in the developed countries [1].
NAFLD is strongly associated with obesity, insulin resistance,
and increased serum levels of saturated free fatty acids (SFA)s
[2]. SFAs are directly hepatotoxic, perhaps by mediating an endo-
plasmic reticulum (ER) stress response, and inducing hepatocyte
apoptosis, referred to as lipoapoptosis or lipotoxicity.
Several studies have implicated ER stress in lipotoxicicity
[3,4]. There are three resident trans-membrane-ER proteins, that
sense and transduce the ER stress response, and their down-
stream mediators serve as ER stress markers. Biosensors of ER
stress include: (1) protein kinase RNA-like ER kinase (PERK); (2)
inositol-requiring protein-1a (IRE-1a); and (3) activating tran-
scription factor 6 (ATF6). These three resident trans-membrane-
ER proteins are held inactive by the chaperone glucose-regulated
protein (GRP) 78; however, an excess of unfolded proteins
relieves GRP78 inhibition resulting in activation of the ER stress
transducers. ATF6 and PERK activation drive the expression of
the proapoptotic transcription factor C/EBP-homologous protein
(CHOP). IRE-1a activation creates a spliced form of XBP-1 mRNA,
a transcription factor that promotes degradation of misfolded ER
glycoproteins. IRE-1a also leads to C-Jun N-terminal kinase (JNK)
activation [5,6]. ER stress is a homeostatic process to restore pro-
tein folding in the ER by decreasing protein load, increasing the
abundance of protein chaperones, and enhancing protein degra-
dation. However, sustained or unrelenting ER stress induces cell
death by CHOP induction and JNK activation, the role of CHOP
in lipotoxicity is controversial, as animals genetically deﬁcientJournal of Hepatology 20
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the other hand, has been more strongly implicated in FFA medi-
ated apoptosis in vivo and in vitro [8–10].
JNK activation is fundamental in both the metabolic syndrome
accompanying NAFLD and cellular apoptosis by SFA. For example,
JNK activation has been well recognized in both rodent and
human non alcoholic steatohepatitis (NASH) [8–10]. However,
the precise cellular and molecular mechanisms resulting in JNK
activation have not been fully revealed, and mechanistic insight
into this process may identify therapeutic targets to treat NASH.
The concomitant occurrence of both ER stress markers and JNK
activation has been inferred to indicate JNK activation is down-
stream of ER stress. However, a smoking gun does not always
infer causing and effect. Nature often camouﬂages the true iden-
tity of the assassin, in this instance JNK activation. For example,
several MAP3K have been implicated in JNK activation indepen-
dent of ER stress, including (apoptosis signal-regulating kinase
1) ASK1 [11] and mixed lineage kinases (MLK) [12]. Recently,
the double-stranded RNA-dependent protein kinase (PKR) has
also shown to be a required component of JNK activation in
response to lipids, inﬂammatory stimuli, and ER stress [13]. Thus,
there are multiple pathways converging on JNK activation.
JNK activation in NASH has been presumed to be activated
through ER stress by IRE-1a/ASK pathway. The article by Sharma
et al. in this issue of the Journal of Hepatology challenges this con-
cept and reveals a new mechanism of SFA-induced JNK activa-
tion. In this remarkable study, the authors suggest JNK
activation is mediated by small GTP binding protein Cdc42 (cell
division cycle protein) and Rac1 (Ras-related C3 botulinum toxin
substrate), independent of IRE-1a and ASK1. Cdc42 and Rac1
have been established as critical regulators of JNK in response
to oncogenic growth factors and inﬂammatory cytokines [14],
but their role in SFA-induced JNK activation had not yet been
explored. The authors used siRNA-mediated knockdown of
MLK3, ASK1, IRE-1a in Hepa1c1c7, AML-12 cell lines, and pri-
mary mouse hepatocytes. Silencing MLK3 reduced SFA-induced
JNK activation, without affecting p38 MAPK phosphorylation,
suggesting an important role of MLK3 in SFA induced JNK activa-
tion. Interestingly, silencingMLK3 did not reduce SFA-induced ER
stress markers (i.e., CHOP and sXBP1), suggesting MLK3 activa-
tion was either downstream or independent of ER stress. As an12 vol. 56 j 17–19
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Fig. 1. JNK activation by thapsigargin versus saturated free fatty acid (SFA).
Thapsigargin (TG) induced ER stress activates the transmembrane ER protein IRE-
1a. IRE-1a subsequently activates ASK1 and JNK leading to cell death. MLK-3
contributes to TG induced JNK activation, most probably, downstream of ER
stress. Saturated fatty acids (SFA) induce an ER stress response, which may
activates double-stranded RNA-dependent protein kinase (PKR) leading to JNK
activation. SFA also activates the small GTP binding protein Cdc42 (cell division
cycle protein) and Rac1 (Ras-related C3 botulinum toxin substrate). Direct
interaction between Cdc42 and MLK3 (downstream or parallel to the ER stress)
may then cause SFA-induced JNK activation. Finally, sustained JNK activation may
also potentially be mediated by direct interaction between MLK-3 and GSK-3b,
leading to a feed forward mechanism for this process. By whatever mechanism,
JNK activation is a key mediator of apoptosis.
Editorialimportant control, silencing MLK3 reduced JNK activation associ-
ated with thapsigargin (TG; a protein glycosylation inhibitor
which is classically used to induce ER stress), suggesting MLK3/
JNK activation may be downstream of ER stress. Although, ASK1
and IRE-1 a have a major role in JNK activation through ER stress
induced by TG, they were dispensable for saturated FFA-associ-
ated JNK activation. These data dispel the myth that SFA-induced
JNK activation is due to IRE-1a/ASK axis. This study also demon-
strates that silencing both Cdc42 and Rac1 concomitantly strongly
inhibits SFA-induced JNK activation. The exact mechanism of
SFA-induced Cdc42 and Rac1 activation was not addressed in this
study. However, direct interaction between Cdc42 and MLK3 was
required for SFA-induced JNK activation. Finally, the authors
demonstrate that hepatocytes depleted of Cdc42/Rac1 or MLK
3, but not IRE1a, are protected against SFA-induced lipoapopto-
sis. Altogether, these results reveal that the small GTPases
Cdc42 and Rac1 are major components of the SFA stimulated sig-
naling pathway that regulates MLK3-dependent JNK activation in
hepatocytes, independent of the ER stress transducer IRE-1a.18 Journal of Hepatology 20A recent study by us demonstrated that inhibition of glycogen
synthase kinase, (GSK)-3a and b, serine/threonine kinases, by
either pharmacological inhibitors or shRNA technology, also
attenuates SFA-induced JNK activation, without affecting other
markers of SFA-induced ER stress response [15]. Several studies
have suggested that GSK-3b is involved in JNK activation through
interaction with upstream MAP3Ks such as MLK-3 or MEKK1 in
neuronal and kidney cell lines [16,17]. MLK-3 may also be regu-
lated by JNK-mediated phosphorylation. These observations
suggest the existence of a feed forward loop where JNK activates
GSK-3 b which in turn activates MLK-3 further enhancing JNK
activating phosphorylation [18]. Thus, emerging data indicate a
unique, yet incompletely understood complex process for SFA-
mediated JNK activation.
The integrative analyses of our data with the results of Shar-
ma et al., point to a novel pathway of SFA-induced JNK activa-
tion (Fig. 1). SFA-induced JNK activation is mediated by direct
interaction between CdC42/Rac1 and MLK-3 (downstream or
parallel to the ER stress). A key question remains, is ER stress
still responsible of JNK activation independent of IRE1a/ASK or
is ER stress an epiphenomenon in this process? GSK-3 may par-
ticipate in this process by directly phosphorylating MLK3 in feed
forward loop involving JNK as described above and depicted in
Fig. 1. Future direction for research in the ﬁeld should include
exploration of the molecular pathways mediating JNK activation
including a role for PKR, the exact mechanism of SFA-mediated
Cdc42/Rac1 activation, and a potential interaction between GSK-
3 and MLK-3.
Two JNK isoforms exist in the liver, many investigators have
implicated JNK 1 in lipotoxicity [19,20]. However, not all
investigators agree that these isoforms mediate different cellular
process (Roger Davis, University of Massachusetts, personal
communication); whether JNK1 and JNK2 execute redundant
pathways or isoform speciﬁc cytoxic cascades, was not examined
in the current study and will require further deﬁnition.
Because indiscriminate pharmacologic JNK inhibition may not
be advisable, unraveling and elucidating the intricacies of SFA-
induced JNK activation are important. Inhibiting a potentially
speciﬁc or unique SFA-induced pathway could ultimately be ther-
apeutically beneﬁcial in NASH. We await such studies with antic-
ipation; our patients are still in need of therapy!
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